Can Long-Term Follow-Up Strategies Be Determined Using a Nomogram-Based Prediction Model of Malignancy Among Intraductal Papillary Mucinous Neoplasms of the Pancreas?

Abstract

The ability of the nomogram to predict malignancy in patients with IPMN was validated. Our findings can suggest that a follow-up for patients at high and low risk for cancer progression could be scheduled every 3 to 6 and 12 months, respectively.